Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
World ADC LondonWorld ADC London
Not Confirmed
Not Confirmed
03-06 March, 2025
Not Confirmed
Not Confirmed
04-06 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
World ADC LondonWorld ADC London
Industry Trade Show
Not Confirmed
03-06 March, 2025
Industry Trade Show
Not Confirmed
04-06 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
15 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mission-therapeutics-announces-publication-in-nature-reviews-drug-discovery-of-article-highlighting-how-neurodegenerative-diseases-can-be-tackled-by-enhancing-mitophagy-302350801.html
02 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mission-therapeutics-awarded-5-2m-from-the-michael-j-fox-foundation-and-parkinsons-uk-to-advance-potential-disease-modifying-treatment-mtx325--302187338.html
14 Mar 2024
// Ayisha Sharma ENDPTS
https://endpts.com/pfizer-backed-mission-therapeutics-raises-25m-to-advance-mitophagy-pipeline/
14 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mission-therapeutics-announces-us-fda-approval-to-initiate-phase-ii-clinical-trial-of-its-lead-asset-mtx652-in-acute-kidney-injury-302014249.html
05 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mission-therapeutics-granted-mhra-clinical-trial-authorisation-cta-for-mtx325-for-the-treatment-of-parkinsons-disease-302005510.html
13 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mission-therapeutics-announces-publication-in-nature-communications-outlining-potential-of-experimental-drug-mtx325-as-a-disease-modifying-therapy-for-parkinsons-disease-301984996.html
ABOUT THIS PAGE